英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Damascena查看　Damascena　在百度字典中的解释百度英翻中〔查看〕
Damascena查看　Damascena　在Google字典中的解释Google英翻中〔查看〕
Damascena查看　Damascena　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • for ZOKINVY.
    ZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies Based upon its mechanism of action, ZOKINVY would not be expected to be effective in these populations
  • This label may not be the latest approved by FDA. For current labeling . . .
    ZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies Based upon its mechanism of action, ZOKINVY would not be expected to be effective in
  • ZOKINVY- lonafarnib capsule Sentynl Therapeutics, Inc.
    Limitations of Use ZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies Based upon its mechanism of action, ZOKINVY would not be expected to be effective in these populations
  • FDA Label for Zokinvy Capsule Oral - Indications, Usage Precautions
    ZOKINVY is indicated in patients 12 months of age and older with a body surface area (BSA) of 0 39 m 2 and above: To reduce the risk of mortality in Hutchinson-Gilford Progeria Syndrome (HGPS)
  • Zokinvy, lonafarnib - European Medicines Agency
    Both studies were single-centre, open-label, single-arm trials that evaluated the efficacy and safety of lonafarnib in patients with genetically confirmed HGPS or a processing-deficient progeroid laminopathy
  • label - . NET Framework
    ZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies Based upon its mechanism of action, ZOKINVY would not be expected to be effective in these populations
  • Annotation of FDA Label for lonafarnib and LMNA, ZMPSTE24
    Excerpts from the lonafarnib (ZOKINVY) drug label: ZOKINVY is a farnesyltransferase inhibitor indicated in patients 12 months of age and older with a body surface area of 0 39 m2 and above: (1) To reduce risk of mortality in Hutchinson-Gilford Progeria Syndrome
  • Zokinvy (Sentynl Therapeutics, Inc. ): FDA Package Insert
    ZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies Based upon its mechanism of action, ZOKINVY would not be expected to be effective in these populations
  • Zokinvy - Eiger BioPharmaceuticals, Inc.
    ZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies Based upon its mechanism of action, ZOKINVY would not be expected to be effective in these populations
  • Zokinvy - FDA Drug Approval Details
    Approved FDA drug approval for Zokinvy by Sentynl Therapeutics, Inc View regulatory information, product details, labeling, and manufacturer information





中文字典-英文字典  2005-2009